Clinical Trial Update: Efficacy Study of CLR3001 in Depression

View source ↗

Summary

An efficacy study of CLR3001 in depression has completed (NCT01158547), sponsored by Clera Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• CLR3001

Snippet

Sponsor: Clera Inc. | Conditions: Depression | Status: COMPLETED